View in EDS HTML Full Text PDF Full Text

Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15th-16th February 2019, Doha, Qatar.

Saved in:
Bibliographic Details
Title: Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15th-16th February 2019, Doha, Qatar.
Authors: Guerrouahen B; Research Department, Sidra Medicine, Doha, Qatar., Elnaggar M; Research Department, Sidra Medicine, Doha, Qatar., Al-Mohannadi A; Research Department, Sidra Medicine, Doha, Qatar., Kizhakayil D; Research Department, Sidra Medicine, Doha, Qatar., Bonini C; Experimental Hematology Unit, University Vita-Salute San Raffaele and Hospital San Raffaele Scientific Institute, Milan, Italy., Benjamin R; Division of Cancer Studies, King's College Hospital, London, United Kingdom., Brentjens R; Cellular Therapeutics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Buchholz CJ; Research Unit for Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Casorati G; Experimental Immunology Unit, University Vita-Salute San Raffaele and Hospital San Raffaele Scientific Institute, Milan, Italy., Ferrone S; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States., Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, United States., Martin F; Pfizer/University of Granada/Andalusian Regional Government, Genomic Medicine Department, Granada, Spain., Schambach A; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boson, MA, United States., Turtle C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Veys P; Bone Marrow Transplant Unit, Great Ormond Street (GOS) Hospital, and University College London GOS Institute of Child Health, London, United Kingdom., van der Vliet HJ; Hans van Der Vliet, Department of Medical Oncology, Amsterdam UMC, VU University and Cancer Center, Amsterdam, Netherlands.; Lava Therapeutics, Utrecht, Netherlands., Maccalli C; Research Department, Sidra Medicine, Doha, Qatar.
Corporate Authors: EICCI Faculty Group
Source: Frontiers in immunology [Front Immunol] 2021 Jan 14; Vol. 11, pp. 589381. Date of Electronic Publication: 2021 Jan 14 (Print Publication: 2020).
Publication Type: Conference Proceedings; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2020.589381